BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tian Y, Bai F, Zhang D, Isaguliants M. HIF1α: A Novel Biomarker with Potential Prognostic and Immunotherapy in Pan-cancer. Oxidative Medicine and Cellular Longevity 2022;2022:1-17. [DOI: 10.1155/2022/1246267] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Yang D, Liu M, Jiang J, Luo Y, Wang Y, Chen H, Li D, Wang D, Yang Z, Chen H. Comprehensive Analysis of DMRT3 as a Potential Biomarker Associated with the Immune Infiltration in a Pan-Cancer Analysis and Validation in Lung Adenocarcinoma. Cancers (Basel) 2022;14. [PMID: 36551704 DOI: 10.3390/cancers14246220] [Reference Citation Analysis]
2 Ye Q, Huang Z, Lu W, Yan F, Zeng W, Xie J, Zhong W. Identification of the common differentially expressed genes and pathogenesis between neuropathic pain and aging. Front Neurosci 2022;16:994575. [DOI: 10.3389/fnins.2022.994575] [Reference Citation Analysis]
3 Miao Y, Liu J, Liu X, Yuan Q, Li H, Zhang Y, Zhan Y, Feng X. Machine learning identification of cuproptosis and necroptosis-associated molecular subtypes to aid in prognosis assessment and immunotherapy response prediction in low-grade glioma. Front Genet 2022;13:951239. [DOI: 10.3389/fgene.2022.951239] [Reference Citation Analysis]